Estrella Immunopharma regains Nasdaq compliance on bid price and market value

Estrella Immunopharma, Inc.

Regained compliance with Nasdaq minimum bid price rule (5550(a)(2)) after 10 consecutive days of closing bid ≥ $1.00 (Sept 9-22, 2025).
Regained compliance with Nasdaq minimum market value of listed securities rule (5550(b)(2)) after 17 consecutive days of MV ≥ $35M (Aug 28-Sept 22, 2025).
Both compliance matters are now closed; previously disclosed non-compliance resolved.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.